Parabilis Medicines
Parabilis Medicines (formerly FogPharma) is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, developing a new class of ultra-tunable alpha-helical peptide therapeutics called Helicons to reach intracellular protein targets long considered undruggable. Its AI- and physics-based discovery platform underpins a pipeline led by zolucatetide, a candidate targeting the beta-catenin / TCF interaction in the Wnt signaling pathway across multiple cancers. Backed by more than $500M from leading life sciences investors and public since its June 2026 IPO (Nasdaq: PBLS), the company was surfaced as a portfolio company of General Catalyst and GV. It publishes a public marketing and investor web presence and a science/data tech blog, but exposes no public developer API surface.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Parabilis Medicines the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Parabilis Medicines scores 14.3/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Parabilis Medicines
Each block below is one kind of artifact we hold for Parabilis Medicines. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Parabilis Medicines — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/parabilis-medicines · machine-readable index on apis.io